• Latest Posts

Kamada and Baxter extend their collaboration in Lung Transplant

A Dutch entrepreneur curing his ALS disease became BIO’s Superhero

Medigene plans to fund its T-cell program with €50 Millions

American Companies are Invading London’s Biotech Stock Market

Biotech to Revolutionize the Millennial Production of Carmine!

BIO2015: Over and Out!

ADVERTISEMENT

Celyad, the new face of Cardio3, is launching an IPO on NASDAQ

Servier disburses €114 Million for Taiho’s Colorectal Cancer treatment

German Viral Vector Producer SIRION pursues its American dream and opens in Boston

Innovate UK accelerates Sareum’s fight against Leukemia

Deinove to challenge the Carotenoid Business

ADVERTISEMENT